AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36399969 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 (30 μg)
Number of subjects: 340
Study 36399969 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose mRNA-1273 (50 μg)
Number of subjects: 340
Study 36399969 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 (100 μg)
Number of subjects: 340
Study 36399969 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC-COV1901 (15 μg)
Number of subjects: 340
Study 36399969 — intervention group
Group type: EXPERIMENTAL
Intervention: All booster vaccines
Number of subjects: 340
Study 36399969 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA vaccines
Number of subjects: 340
Study 32172626 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual treatment
Number of subjects: 322
Study 32172626 — intervention group
Group type: EXPERIMENTAL
Intervention: Community outings
Number of subjects: 322
Study 32273122 — intervention group
Group type: EXPERIMENTAL
Intervention: Stick™ resin treatment
Number of subjects: 100
Study 32273122 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylene glycol + triazabicyclodecene treatment
Number of subjects: 100
Study 32273122 — intervention group
Group type: COMPARATOR
Intervention: Control group (0s)
Number of subjects: 100
Study 34519555 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led education program for stroke patients, 20-week duration
Number of subjects: 92
Study 34949227 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic yoga protocol (DYP)
Number of subjects: 184
Study 34244703 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus aspirin
Number of subjects: 3312
Study 34244703 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 3312
Study 32336148 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (⩽5 treatment cycles) in the upper limb
Number of subjects: 599
Study 32336148 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (⩽5 treatment cycles) in the lower limb
Number of subjects: 599
Study 32336148 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (⩽5 treatment cycles)
Number of subjects: 599
Study 34260948 — intervention group
Group type: EXPERIMENTAL
Intervention: FHR proteins (FHR-1, FHR-2, FHR-3, FHR-4, FHR-5) and FHL-1 concentrations measured using a targeted mass-spectrometry assay
Number of subjects: 352
Study 34260948 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=252)
Number of subjects: 352
Study 36285406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 36285406 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone-bupropion
Number of subjects: 136
Study 36285406 — intervention group
Group type: EXPERIMENTAL
Intervention: BWL+placebo
Number of subjects: 136
Study 36285406 — intervention group
Group type: EXPERIMENTAL
Intervention: BWL+naltrexone-bupropion
Number of subjects: 136
Study 32811701 — intervention group
Group type: EXPERIMENTAL
Intervention: Playful learning interventions (toys, visual and auditory sources)
Number of subjects: 100
Study 32811701 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional instruction)
Number of subjects: 100
Study 32584677 — intervention group
Group type: EXPERIMENTAL
Intervention: AG (nab-paclitaxel with gemcitabine)
Number of subjects: 2199
Study 32584677 — intervention group
Group type: EXPERIMENTAL
Intervention: FFX (FOLFIRINOX)
Number of subjects: 2199
Study 34533869 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% 1RM
Number of subjects: 26
Study 34533869 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% 1RM (100% workload)
Number of subjects: 26
Study 34533869 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% 1RM
Number of subjects: 26
Study 34533869 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% 1RM (50% workload)
Number of subjects: 26
Study 34533869 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 26
Study 34533869 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate and vigorous intensity exercise
Number of subjects: 26
Study 34533869 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular activity
Number of subjects: 26
Study 32615892 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing meditation
Number of subjects: 73
Study 32615892 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 73
Study 32615892 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 73
Study 36114491 — intervention group
Group type: EXPERIMENTAL
Intervention: Dibutyl phthalate (DBP) exposure
Number of subjects: 16
Study 32339253 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (80 mg/m2 on day 1, 8, and 15) plus everolimus (10 mg daily, arm B)
Number of subjects: 300
Study 32339253 — intervention group
Group type: COMPARATOR
Intervention: Placebo (arm A)
Number of subjects: 300
Study 32339253 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (80 mg/m2) plus everolimus (10 mg daily) in patients with prior taxane use
Number of subjects: 300
Study 32339253 — intervention group
Group type: COMPARATOR
Intervention: Placebo in patients with prior taxane use
Number of subjects: 300
Study 32339253 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel plus everolimus
Number of subjects: 300
Study 32339253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 36115817 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin plus fluoropyrimidine in Group 1
Number of subjects: 491
Study 36115817 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine in Group 2
Number of subjects: 491
Study 36115817 — intervention group
Group type: COMPARATOR
Intervention: Fluoropyrimidine in Group 1
Number of subjects: 491
Study 36115817 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine with observation in Group 2
Number of subjects: 491
Study 33206309 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic therapy (ST) after RT (n = 999)
Number of subjects: 3095
Study 33206309 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted therapy after RT
Number of subjects: 3095
Study 33206309 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy after RT
Number of subjects: 3095
Study 33206309 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytotoxic chemotherapy after RT
Number of subjects: 3095
Study 33206309 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy after RT
Number of subjects: 3095
Study 33206309 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of ST after RT
Number of subjects: 3095
Study 33206309 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram predicting OS
Number of subjects: 3095
Study 33206309 — intervention group
Group type: COMPARATOR
Intervention: No ST before or after RT (Control group, n = 2096)
Number of subjects: 3095
Study 33544562 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider with at least 10 previous insertions
Number of subjects: 1232
Study 33544562 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger than 21 years
Number of subjects: 1232
Study 33544562 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalit caste
Number of subjects: 1232
Study 33544562 — intervention group
Group type: EXPERIMENTAL
Intervention: Husbands not living at home
Number of subjects: 1232
Study 34791320 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBI
Number of subjects: 246
Study 34791320 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-FI
Number of subjects: 246
Study 34791320 — intervention group
Group type: COMPARATOR
Intervention: RVE
Number of subjects: 246
Study 34791320 — intervention group
Group type: COMPARATOR
Intervention: AC
Number of subjects: 246
Study 34948547 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect exergames
Number of subjects: 23
Study 34948547 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii exergames
Number of subjects: 23
Study 34948547 — intervention group
Group type: COMPARATOR
Intervention: Both Kinect and Wii exergames
Number of subjects: 23
Study 33262584 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 320
Study 33262584 — intervention group
Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy (COT)
Number of subjects: 320
Study 35387830 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated lyophilised faecal microbiota transplantation (FMT)
Number of subjects: 120
Study 35387830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 34387964 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol + Ibuprofen (PCM + IBU)
Number of subjects: 556
Study 34387964 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (PCM)
Number of subjects: 556
Study 34387964 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU)
Number of subjects: 556
Study 34387964 — intervention group
Group type: EXPERIMENTAL
Intervention: Half Strength-Paracetamol + Ibuprofen (HS-PCM + IBU)
Number of subjects: 556
Study 34387964 — intervention group
Group type: COMPARATOR
Intervention: Non-opioid analgesics before surgery
Number of subjects: 556
Study 34387964 — intervention group
Group type: COMPARATOR
Intervention: Weak opioids before surgery
Number of subjects: 556
Study 34387964 — intervention group
Group type: COMPARATOR
Intervention: No analgesics before surgery
Number of subjects: 556
Study 32774071 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE/HAIC + S‐1
Number of subjects: 115
Study 32774071 — intervention group
Group type: COMPARATOR
Intervention: TACE/HAIC
Number of subjects: 115
Study 36438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood-based HIV self-testing
Number of subjects: 24
Study 36438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral HIV self-testing
Number of subjects: 24
Study 36438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice arm
Number of subjects: 24
Study 36438254 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC) arm
Number of subjects: 24
Study 34211410 — intervention group
Group type: EXPERIMENTAL
Intervention: Mangosteen pericarp extract supplementation
Number of subjects: 114
Study 34211410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 32643543 — intervention group
Group type: EXPERIMENTAL
Intervention: Group hypnosis sessions (5 weekly sessions plus audio recordings)
Number of subjects: 12
Study 36253041 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured rehabilitation
Number of subjects: 60
Study 36253041 — intervention group
Group type: COMPARATOR
Intervention: Non-structured rehabilitation
Number of subjects: 60
Study 33840750 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoes + P-FFO
Number of subjects: 15
Study 33840750 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoes + UCBL
Number of subjects: 15
Study 33840750 — intervention group
Group type: COMPARATOR
Intervention: Shoes only
Number of subjects: 15
Study 32302254 — intervention group
Group type: EXPERIMENTAL
Intervention: Authoritative parenting style
Number of subjects: 554
Study 32302254 — intervention group
Group type: EXPERIMENTAL
Intervention: Authoritarian parenting style
Number of subjects: 554
Study 32302254 — intervention group
Group type: EXPERIMENTAL
Intervention: Permissive parenting style
Number of subjects: 554
Study 32302254 — intervention group
Group type: EXPERIMENTAL
Intervention: Neglectful parenting style
Number of subjects: 554
Study 32302254 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall psychological well-being
Number of subjects: 554
Study 32484228 — intervention group
Group type: EXPERIMENTAL
Intervention: Variants associated with protein levels near IGFBP3 and IGFBP5 genes
Number of subjects: 838
Study 32484228 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 838
Study 35833880 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34147854 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimsuit (objectification condition)
Number of subjects: 52
Study 34147854 — intervention group
Group type: COMPARATOR
Intervention: Sweater (control condition)
Number of subjects: 52
Study 35134661 — intervention group
Group type: EXPERIMENTAL
Intervention: True RIPC (inflation of upper extremity blood pressure cuff thrice to 30 mmHg above systolic blood pressure for 5 min)
Number of subjects: 25
Study 35134661 — intervention group
Group type: COMPARATOR
Intervention: Sham RIPC (inflation of blood pressure cuff thrice to 30 mmHg for 5 min)
Number of subjects: 25
Study 35134661 — intervention group
Group type: EXPERIMENTAL
Intervention: True RIPC
Number of subjects: 25
Study 35134661 — intervention group
Group type: COMPARATOR
Intervention: Sham RIPC
Number of subjects: 25
Study 33902621 — intervention group
Group type: EXPERIMENTAL
Intervention: RPH-104 80 mg
Number of subjects: 102
Study 33902621 — intervention group
Group type: EXPERIMENTAL
Intervention: RPH-104 160 mg
Number of subjects: 102
Study 33902621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 34802107 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbed reposition pharyngoplasty (BRP) surgery with preoperative drug-induced sleep endoscopy (DISE) evaluation (Group B)
Number of subjects: 92
Study 34802107 — intervention group
Group type: COMPARATOR
Intervention: Barbed reposition pharyngoplasty (BRP) surgery without preoperative drug-induced sleep endoscopy (DISE) evaluation (Group A)
Number of subjects: 92
Study 34802107 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 92
Study 32881123 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous Bone (AB)
Number of subjects: 50
Study 32881123 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic Bone Graft Material (BBGM)
Number of subjects: 50
Study 36231972 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (Sprint Interval Training)
Number of subjects: 37
Study 36231972 — intervention group
Group type: COMPARATOR
Intervention: CONT (Control group)
Number of subjects: 37
Study 32541365 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ PanOptix TFNT00 IOL (n=93)
Number of subjects: 182
Study 32541365 — intervention group
Group type: COMPARATOR
Intervention: AT LISA tri 839MP IOL (n=89)
Number of subjects: 182
Study 35686709 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated CXL (9 mW/cm2, 10 min)
Number of subjects: 27
Study 35686709 — intervention group
Group type: COMPARATOR
Intervention: Standard CXL (3 mW/cm2, 30 min)
Number of subjects: 27
Study 35686709 — intervention group
Group type: COMPARATOR
Intervention: Standard CXL
Number of subjects: 27
Study 35686709 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated CXL
Number of subjects: 27
Study 33241770 — intervention group
Group type: EXPERIMENTAL
Intervention: [11C]DASB with MCZ
Number of subjects: 159
Study 33241770 — intervention group
Group type: EXPERIMENTAL
Intervention: [11C]SB207145 with MCZ
Number of subjects: 159
Study 33241770 — intervention group
Group type: EXPERIMENTAL
Intervention: Permutation testing
Number of subjects: 159
Study 36148821 — intervention group
Group type: EXPERIMENTAL
Intervention: RNS60
Number of subjects: 147
Study 36148821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 32914911 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopy-guided injection
Number of subjects: 210
Study 32914911 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection
Number of subjects: 210
Study 32914911 — intervention group
Group type: COMPARATOR
Intervention: Non-image-guided injection
Number of subjects: 210
Study 32401335 — intervention group
Group type: EXPERIMENTAL
Intervention: 105° breast shield
Number of subjects: 49
Study 32401335 — intervention group
Group type: COMPARATOR
Intervention: 90° breast shield
Number of subjects: 49
Study 36164278 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptualizing obesity as a disease
Number of subjects: 365
Study 36164278 — intervention group
Group type: COMPARATOR
Intervention: Not conceptualizing obesity as a disease (control)
Number of subjects: 365
Study 36164278 — intervention group
Group type: EXPERIMENTAL
Intervention: Endorsing weight as a heuristic for health
Number of subjects: 365
Study 33393445 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose 2 g/day for 2 weeks
Number of subjects: 60
Study 33393445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35383066 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month electronic intervention (11 related information pushing and 3 online lectures)
Number of subjects: 0
Study 35383066 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 0
Study 35383066 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month electronic intervention
Number of subjects: 0
Study 34747891 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual patient simulation training
Number of subjects: 21
Study 36294490 — intervention group
Group type: EXPERIMENTAL
Intervention: Belt electrode-skeletal muscle electrical stimulation (B-SES) during hemodialysis for 12 weeks
Number of subjects: 20
Study 36294490 — intervention group
Group type: COMPARATOR
Intervention: Routine care only for 12 weeks
Number of subjects: 20
Study 33904784 — intervention group
Group type: EXPERIMENTAL
Intervention: Group acupuncture (AP)
Number of subjects: 74
Study 33904784 — intervention group
Group type: COMPARATOR
Intervention: Individual acupuncture (AP)
Number of subjects: 74
Study 35302631 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment drugs
Number of subjects: 138235
Study 35302631 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccines
Number of subjects: 138235
Study 35302631 — intervention group
Group type: EXPERIMENTAL
Intervention: Other interventions
Number of subjects: 138235
Study 36287530 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent irrigation throughout the day (T1) with Plowless cultivation (W1)
Number of subjects: 3
Study 36287530 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation two days after water disappears from the soil (T2) with Plowless cultivation (W1)
Number of subjects: 3
Study 36287530 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent soil saturation (T3) with Plowless cultivation (W1)
Number of subjects: 3
Study 36287530 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent soil saturation (T3) with stack 60 cm (W2)
Number of subjects: 3
Study 36287530 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation two days after water disappears from the soil (T2) with stack 60 cm (W2)
Number of subjects: 3
Study 36287530 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent irrigation throughout the day (T1) with stack 80 cm (W3)
Number of subjects: 3
Study 33957337 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical estradiol (2 mg)
Number of subjects: 212
Study 33957337 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief of receiving estradiol treatment
Number of subjects: 212
Study 35553373 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, progressive exercise training (ACE+ exercise group)
Number of subjects: 42
Study 35553373 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control (ACE+ control group)
Number of subjects: 42
Study 35553373 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control (ACE- group)
Number of subjects: 42
Study 32770402 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE)
Number of subjects: 0
Study 34627809 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% atropine continued treatment
Number of subjects: 350
Study 34627809 — intervention group
Group type: COMPARATOR
Intervention: 0.05% atropine washout
Number of subjects: 350
Study 34627809 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% atropine continued treatment
Number of subjects: 350
Study 34627809 — intervention group
Group type: COMPARATOR
Intervention: 0.025% atropine washout
Number of subjects: 350
Study 34627809 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine continued treatment
Number of subjects: 350
Study 34627809 — intervention group
Group type: COMPARATOR
Intervention: 0.01% atropine washout
Number of subjects: 350
Study 34627809 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall continued treatment
Number of subjects: 350
Study 34627809 — intervention group
Group type: COMPARATOR
Intervention: Overall washout
Number of subjects: 350
Study 32243070 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodiafiltration (HDF)
Number of subjects: 1115
Study 32149711 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious smartphone game (Resus Days) for 1 hour before ALS lecture
Number of subjects: 105
Study 32149711 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional ALS training alone)
Number of subjects: 105
Study 32149711 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious smartphone game (Resus Days)
Number of subjects: 105
Study 36401274 — intervention group
Group type: EXPERIMENTAL
Intervention: SVV-based goal-directed fluid therapy (GDFT) with 3 ml/kg hydroxyethyl starch solution when SVV > 15% for more than 5 min intraoperatively
Number of subjects: 0
Study 36401274 — intervention group
Group type: COMPARATOR
Intervention: Traditional fluid therapy
Number of subjects: 0
Study 32758205 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine removal of the syndesmotic screw
Number of subjects: 196
Study 32758205 — intervention group
Group type: EXPERIMENTAL
Intervention: On demand removal of the syndesmotic screw
Number of subjects: 196
Study 32758205 — intervention group
Group type: EXPERIMENTAL
Intervention: Total population for the trial
Number of subjects: 196
Study 34415450 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss condition
Number of subjects: 255
Study 34415450 — intervention group
Group type: EXPERIMENTAL
Intervention: CFC‐14 Immediate scale and GRCS dimensions Gambling Expectancies and Interpretative Bias
Number of subjects: 255
Study 34415450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitions related to gambling
Number of subjects: 255
Study 34415450 — intervention group
Group type: EXPERIMENTAL
Intervention: Gambling severity
Number of subjects: 255
Study 34415450 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonchasers and chasers
Number of subjects: 255
Study 34585377 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (trained facilitators making three visits over six months)
Number of subjects: 14633
Study 34585377 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 14633